Secondary and tertiary hyperparathyroidism in chronic kidney disease
In the treatment of secondary hyperparathyroidism of end-stage chronic kidney disease, vitamin D receptor activation and allosteric modulators of the calcium-sensing receptor inhibit glandular hyperplasia, reduce parathyroid hormone levels, impact on bone turnover and mineral density. But the use o...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2017-12-01
|
| Series: | Остеопороз и остеопатии |
| Subjects: | |
| Online Access: | https://osteo-endojournals.ru/osteo/article/viewFile/9427/7107 |